A treatment billed as a potential breakthrough in the fight against disease, including cancer, could back-fire and make the disease fitter and more damaging, new research has found. Ground-breaking research has found that introducing ‘friendlier’ less-potent strains into a population of disease-causing microbes can lead to increased disease severity.